Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations - Test2 - elhamkhani - TriplyDB

Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations

Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations

http://www.wikidata.org/entity/Q27021203

about

Trends and advances in tumor immunology and lung cancer immunotherapy Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors Lung cancer mutations and use of targeted agents in Hispanics Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer An analysis of the gene interaction networks identifying the role of PARP1 in metastasis of non-small cell lung cancer.miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro.Tumor necrosis factor-related apoptosis-inducing ligand additive with Iodine-131 of inhibits non-small cell lung cancer cells through promoting apoptosis.The Efficacy and Toxicity of Gefitinib in Treating Non-small Cell Lung Cancer: A Meta-analysis of 19 Randomized Clinical Trials.

P2860

Q28067674-3E341849-726E-460D-9C6D-756392472AB1 Q28086768-1B77D0D6-0BA4-40A2-9456-454F20D9C9DF Q35636924-C83E3FE8-8960-4EBE-81A8-D5DAB87A15E2 Q39646977-DE1924B4-3EDF-4BB3-8E44-91D71A334B9E Q44000570-5B6AECB5-1C2A-4CFD-BEA9-C72EFBAA7C9C Q47093759-B267A374-F2D7-4D55-8200-0E004BD65C35 Q55240083-FC7858FD-8BF1-4F5F-9D8D-94592DCA6D08 Q55409671-53F22744-556B-4D95-B525-78F19B4DF1D7

P2860

Advanced EGFR mutation-positive non-small-cell lung cancer: case report, literature review, and treatment recommendations

http://www.wikidata.org/entity/Q27021203

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Advanced EGFR mutation-positiv ...... and treatment recommendations

@ast

Advanced EGFR mutation-positiv ...... and treatment recommendations

@en

Advanced EGFR mutation-positiv ...... and treatment recommendations

@nl

type

label

Advanced EGFR mutation-positiv ...... and treatment recommendations

@ast

Advanced EGFR mutation-positiv ...... and treatment recommendations

@en

Advanced EGFR mutation-positiv ...... and treatment recommendations

@nl

prefLabel

Advanced EGFR mutation-positiv ...... and treatment recommendations

@ast

Advanced EGFR mutation-positiv ...... and treatment recommendations

@en

Advanced EGFR mutation-positiv ...... and treatment recommendations

@nl

P1433

Q27021203-E6CB174A-B476-4987-8895-42D3B996C438

P1476

Q27021203-700FAB29-6BBA-42CA-BDBC-C9ED3EC8A2F7

P2093

Q27021203-3C966F4F-7F0D-4222-A780-AB2DCAF35F16

Q27021203-5EA2C852-8737-4F01-90CA-79441E8C4531

P2860

Q27021203-03C03E8E-1882-40F2-B45D-B324181F964E

Q27021203-10557D03-4D59-4F02-80CE-2C8539AEB50C

Q27021203-126CFBA5-333D-4E7F-B7A1-9D9CD92BBD51

Q27021203-20289DFE-CEA0-488D-ADBF-45F815FED974

Q27021203-2CDE25D9-0465-4F18-8CF5-97C3B915D54F

Q27021203-3B93C55B-6636-41B6-A40A-D0A2F6313660

Q27021203-3D81963B-8BF3-4FEA-AD94-A2E3ACFC1BED

Q27021203-3E021402-889B-4E06-A28A-5509BF19592A

Q27021203-42FBEEA0-D5D7-4DAB-80B4-8513F8C534F8

Q27021203-4A455422-A06D-4EB5-BE0E-8E03F8B79E61

P304

Q27021203-BBBA8091-5964-4696-A902-4655284FC677

P31

Q27021203-BF82C72F-29BA-4997-BFDD-2AC46463911D

P356

Q27021203-C72D12D7-7004-4F1C-B544-B0B0CA0614AD

P407

Q27021203-2A4FDA61-8DE0-4299-88EE-CE9C8785B7FB

P433

Q27021203-0CA34844-99FA-4393-9F16-C11857AAC399

P478

Q27021203-609515EA-08E3-4ECA-9751-A0AB84A11BDE

P577

Q27021203-20209A09-6FB0-45B7-8D51-C1E77AABBB0C

P698

Q27021203-9B4C1391-5D14-4172-BB93-297823B51B59

P356

107327481402100110

P1433

P1476

Advanced EGFR mutation-positiv ...... and treatment recommendations

@en

P2093

Chiappori A

http://www.w3.org/2001/XMLSchema#string

Kuykendall A

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

Cancer statistics, 2013

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

P304

67-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481402100110

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24357744

http://www.w3.org/2001/XMLSchema#string